The Electrophoresis Market reagent segment is dominating the product segment due to the rising demand protein separation via for 2D electrophoresis in various applications such as protein mapping, diagnosis of chronic diseases, and others. This in turn drives the growth of the electrophoresis market.
The Electrophoresis Market is projected to grow at a significant pace reaching a CAGR of approximately 6.2%, over the forecast period of 2022–2028, despite a considerable fall in Application sales during the initial phase of pandemic spread and lockdown restrictions imposed globally.
In a recent research report by Reports Insight Consulting Pvt. Ltd, the Electrophoresis Market is expected to surpass USD 4.81 Billion by the year 2028, from USD 3.16 Billion in 2021.
Electrophoresis is techniques use to physically separate the macromolecules such as nucleic acid fragments, RNA, and other. Gel electrophoresis and capillary electrophoresis are preferred techniques for efficient analytical partition of macromolecules.
Regional segments, include, North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. North America is expected to have a significant market in the forecast period. The factors responsible for the growth of the market are increasing investment in healthcare facilities and drug discovery. Further, increasing focus on research and development by key players in the region is anticipated to support the growth of the market.
The study is consolidated into major segments and further into sub-segments, such as by Product (Electrophoresis Reagents, Electrophoresis Systems, Gel Documentation Systems, Electrophoresis Software), Electrophoresis Market Application (Research, Diagnostics, Quality Control Process Validation), End User (Academic Research Institutes, Pharmaceutical Biotechnology Companies, Hospitals, Other End Users), to forecast the market size by value; also includes the analysis of past Dynamics from 2016 – 2021, considering 2021 as the base year.
Lastly, the report includes a regional analysis and country analysis with the latest trends, along with the major key players including Thermo Fisher Scientific Inc, Bio-Rad Laboratories, Inc., Merck Group, Agilent Technologies, Inc., Danaher Corporation, GE Healthcare, PerkinElmer Inc., QIAGEN N.V., Harvard Bioscience, Inc., Shimadzu Corporation, Lonza Group Ltd., Sebia Group, C.B.S. Scientific Company, Inc., Helena Laboratories, Takara Bio, Inc., Teledyne Technologies, VWR International, and TBG Diagnostic Ltd.
Contact:
